MedTrace Logo

Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia

NCT01346891 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2011-07-06

No results posted yet for this study

Summary

The purpose of this study is to detect if there are any differences in the coding region of SLC12A3 gene in individuals who have had hyponatremia associated to the use of thiazides, and those thiazides consumers without hyponatremia that have demonstrated good tolerance to the drug.

Conditions

  • Thiazide Diuretics Induced Hyponatremia

Sponsors & Collaborators

  • Sociedad Argentina de Hipertension Arterial (SAHA)

    collaborator OTHER

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Diego H Giunta, MD · Hospital Italiano de Buenos Aires

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31

Countries

  • Argentina

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346891 on ClinicalTrials.gov